584 related articles for article (PubMed ID: 21256535)
21. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
[TBL] [Abstract][Full Text] [Related]
22. Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis.
Campello E; Spiezia L; Radu CM; Bon M; Gavasso S; Zerbinati P; Woodhams B; Tormene D; Prandoni P; Simioni P
Thromb Haemost; 2012 Oct; 108(4):633-9. PubMed ID: 22836806
[TBL] [Abstract][Full Text] [Related]
23. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.
Auwerda JJ; Yuana Y; Osanto S; de Maat MP; Sonneveld P; Bertina RM; Leebeek FW
Thromb Haemost; 2011 Jan; 105(1):14-20. PubMed ID: 21057704
[TBL] [Abstract][Full Text] [Related]
24. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
25. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation.
Thaler J; Koder S; Kornek G; Pabinger I; Ay C
Transl Res; 2014 Feb; 163(2):145-50. PubMed ID: 23973167
[TBL] [Abstract][Full Text] [Related]
26. Studies of microparticles in patients with the antiphospholipid syndrome (APS).
Vikerfors A; Mobarrez F; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Antovic A; Wallén H; Svenungsson E
Lupus; 2012 Jun; 21(7):802-5. PubMed ID: 22635239
[TBL] [Abstract][Full Text] [Related]
27. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
[TBL] [Abstract][Full Text] [Related]
28. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology.
Kleinjan A; Böing AN; Sturk A; Nieuwland R
Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670
[TBL] [Abstract][Full Text] [Related]
29. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
[TBL] [Abstract][Full Text] [Related]
30. Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity.
Trappenburg MC; van Schilfgaarde M; Frerichs FC; Spronk HM; ten Cate H; de Fijter CW; Terpstra WE; Leyte A
Nephrol Dial Transplant; 2012 Apr; 27(4):1446-53. PubMed ID: 21873622
[TBL] [Abstract][Full Text] [Related]
31. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
[TBL] [Abstract][Full Text] [Related]
32. Annexin V
Chen Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Cao X; Zhang W; Liu L; Wu J
Clin Chim Acta; 2022 Nov; 536():169-179. PubMed ID: 36191610
[TBL] [Abstract][Full Text] [Related]
33. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
34. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer.
Hron G; Kollars M; Weber H; Sagaster V; Quehenberger P; Eichinger S; Kyrle PA; Weltermann A
Thromb Haemost; 2007 Jan; 97(1):119-23. PubMed ID: 17200778
[TBL] [Abstract][Full Text] [Related]
35. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress.
Helal O; Defoort C; Robert S; Marin C; Lesavre N; Lopez-Miranda J; Risérus U; Basu S; Lovegrove J; McMonagle J; Roche HM; Dignat-George F; Lairon D
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):665-71. PubMed ID: 20399083
[TBL] [Abstract][Full Text] [Related]
37. Microparticle formation after exposure of blood to activated endothelium under flow.
Macey MG; Wolf SI; Lawson C
Cytometry A; 2010 Aug; 77(8):761-8. PubMed ID: 20653016
[TBL] [Abstract][Full Text] [Related]
38. Formation of microparticles in the injured brain of patients with severe isolated traumatic brain injury.
Nekludov M; Mobarrez F; Gryth D; Bellander BM; Wallen H
J Neurotrauma; 2014 Dec; 31(23):1927-33. PubMed ID: 24956150
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
Christersson C; Johnell M; Siegbahn A
Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
[TBL] [Abstract][Full Text] [Related]
40. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]